Clinical symptoms, diagnosis, and treatment of neurocysticercosis

被引:343
|
作者
Garcia, Hector H. [1 ,2 ,3 ]
Nash, Theodore E. [4 ]
Del Brutto, Oscar H. [5 ,6 ]
机构
[1] Inst Ciencias Neurol, Cysticercosis Unit, Lima 1, Peru
[2] Univ Peruana Cayetano Heredia, Ctr Global Hlth Tumbes, Lima, Peru
[3] Univ Peruana Cayetano Heredia, Sch Sci, Dept Microbiol, Lima, Peru
[4] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
[5] Univ Espiritu Santo Ecuador, Sch Med, Guayaquil, Ecuador
[6] Hosp Clin Kennedy, Dept Neurol Sci, Guayaquil, Ecuador
来源
LANCET NEUROLOGY | 2014年 / 13卷 / 12期
基金
英国惠康基金; 美国国家卫生研究院;
关键词
SOLITARY CYSTICERCUS GRANULOMA; TAENIA-SOLIUM TAENIASIS; CENTRAL-NERVOUS-SYSTEM; CALCIFIED NEUROCYSTICERCOSIS; FOLLOW-UP; CEREBRAL CYSTICERCOSIS; SEIZURE RECURRENCE; HYDROCEPHALUS SECONDARY; COGNITIVE IMPAIRMENT; PRAZIQUANTEL THERAPY;
D O I
10.1016/S1474-4422(14)70094-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The infection of the nervous system by the cystic larvae of Taenia solium (neurocysticercosis) is a frequent cause of seizure disorders. Neurocysticercosis is endemic or presumed to be endemic in many low-income countries. The lifecycle of the worm and the clinical manifestations of neurocysticercosis are well established, and CT and MRI have substantially improved knowledge of the disease course. Improvements in immunodiagnosis have further advanced comprehension of the pathophysiology of this disease. This knowledge has led to individualised treatment approaches that account for the involvement of parenchymal or extraparenchymal spaces, the number and form of parasites, and the extent of degeneration and associated inflammation. Clinical investigations are focused on development of effective treatments and reduction of side-effects induced by treatment, such as seizures, hydrocephalus, infarcts, and neuroinjury.
引用
收藏
页码:1202 / 1215
页数:14
相关论文
共 50 条
  • [41] Update on the Diagnosis and Management of Neurocysticercosis
    Webb, Camille M.
    White, A. Clinton, Jr.
    CURRENT INFECTIOUS DISEASE REPORTS, 2016, 18 (12)
  • [42] Neurocysticercosis: Pathophysiology, diagnosis, and management
    Davis, LE
    NEUROLOGIST, 1996, 2 (06) : 356 - 364
  • [43] Neurocysticercosis in a tertiary care hospital. New advances in diagnosis and treatment
    Martinez, EB
    HernandezMora, MD
    Sanchez, JA
    Barnes, PR
    Estrella, MC
    Corral, JLS
    Guerrero, MLF
    REVISTA CLINICA ESPANOLA, 1997, 197 (09): : 604 - 610
  • [44] Recent Advances in the Diagnosis of Neurocysticercosis
    Nicholas A. Gadea
    Gabriela Matamoros
    Maria Mercedes Rueda
    Current Treatment Options in Infectious Diseases, 2018, 10 (3) : 410 - 420
  • [45] Intermittent symptoms in neurocysticercosis: could they be epileptic?
    Pradhan, S
    Kumar, R
    Gupta, RK
    ACTA NEUROLOGICA SCANDINAVICA, 2003, 107 (04): : 260 - 266
  • [46] Clinical aspects of neurocysticercosis
    Takayanagui, OM
    Odashima, NS
    PARASITOLOGY INTERNATIONAL, 2006, 55 : S111 - S115
  • [47] Neurocysticercosis: Pathophysiology, diagnosis, and management
    Davis, LE
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1997, 6 (06) : 358 - 365
  • [48] RADIOLOGICAL-DIAGNOSIS OF NEUROCYSTICERCOSIS
    CAMARGO, CA
    MARSHALL, WH
    PARASITOLOGY TODAY, 1987, 3 (01): : 30 - 31
  • [49] Recent Advances in the Diagnosis of Neurocysticercosis
    Gadea, Nicholas A.
    Matamoros, Gabriela
    Rueda, Maria Mercedes
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2018, 10 (03) : 410 - 420
  • [50] Clinical management of neurocysticercosis
    Del Brutto, Oscar H.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (04) : 389 - 396